• Home |
• Contact Us |
• Sitemap

• About Us
  • Overview
  • Mission & Values
  • Management Team
  • Board of Directors
  • Map & Directions - US
  • Map & Directions - EU
  • Blood Safety for Africa
• Careers
  • Careers - Overview
  • Current Openings - US
  • Current Openings - EU
• Pathogen Inactivation
  • Pathogen Inactivation Today
  • The Need for Blood Safety and Availability
  • Introduction to Blood Banking
• Products
  • INTERCEPT Platelets, Plasma and Red Cells
  • How INTERCEPT Works
  • Case Study
• Investors
  • Investor Overview
  • Corporate Governance
  • Analyst Coverage
  • Press Releases
  • Investor Events
  • Webcasts
  • Annual Reports
  • Annual Meeting
  • SEC Filings
  • Stock Information
  • Email Subscription Form
  • Investor Contacts
  • RSS Feeds
• News & Events
  • News & Events

Global Links Management Team

Investors

Investor Overview Corporate Governance Analyst Coverage Press Releases Investor Events Webcasts Annual Reports Annual Meeting SEC Filings Stock Information Email Subscription Form Investor Contacts RSS Feeds

Analyst Coverage

Firm	Analyst
Robert W. Baird & Co.	Christopher J. Raymond
McNicoll, Lewis & Vlak (MLV)	George Zavoico, Ph.D.
Wedbush	Zarak Khurshid
Cantor Fitzgerald	Jeremy Feffer
Cowen and Company	Josh Jennings, M.D.

Cerus Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cerus Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cerus Corporation or its management. Cerus Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

© 2013 Cerus Corporation

• Legal |
• Privacy